Human-Avatar Symbiosis for the Treatment of Auditory Verbal Hallucinations in Schizophrenia through Virtual/Augmented Reality and Brain-Computer Interfaces.

Human-Avatar Symbiosis for the Treatment of Auditory Verbal Hallucinations in Schizophrenia through Virtual/Augmented Reality and Brain-Computer Interfaces.
复制标题

DOI:
10.3389/fninf.2017.00064
复制
发表时间:
2017
影响因子:
3.5
通讯作者:
Rodriguez-Jimenez R
Rodriguez-Jimenez R
中科院分区:
医学3区
文献类型:
--
作者:
Fernández-Caballero A;Navarro E;Fernández-Sotos P;González P;Ricarte JJ;Latorre JM;Rodriguez-Jimenez R

文献摘要

参考文献

被引文献

相似文献

这篇观点论文面临着替代治疗的未来,这些治疗利用社会和认知方法来治疗精神分裂症患者的听觉言语幻觉(AVH)的药物治疗。AVH是在没有听觉刺激的情况下对声音的感知,代表着一种严重的精神健康症状。虚拟/增强现实(VR/AR)和脑机接口(BCI)技术在不同的医疗和心理应用中得到了越来越多的发展。我们的立场是,它们在基于计算机的治疗中的结合使用,为身体和精神残疾的治疗提供了仍然无法预见的可能性。这就是为什么,论文期望研究人员和临床医生充分利用新技术,走出一条AVH人-化身共生的道路。这一展望旨在解决在理解精神分裂症相关疾病的非药物治疗以及利用VR/AR和BCI实现真正的人与化身共生方面具有挑战性的问题。
This perspective paper faces the future of alternative treatments that take advantage of a social and cognitive approach with regards to pharmacological therapy of auditory verbal hallucinations (AVH) in patients with schizophrenia. AVH are the perception of voices in the absence of auditory stimulation and represents a severe mental health symptom. Virtual/augmented reality (VR/AR) and brain computer interfaces (BCI) are technologies that are growing more and more in different medical and psychological applications. Our position is that their combined use in computer-based therapies offers still unforeseen possibilities for the treatment of physical and mental disabilities. This is why, the paper expects that researchers and clinicians undergo a pathway toward human-avatar symbiosis for AVH by taking full advantage of new technologies. This outlook supposes to address challenging issues in the understanding of non-pharmacological treatment of schizophrenia-related disorders and the exploitation of VR/AR and BCI to achieve a real human-avatar symbiosis.
DOI: 10.1017/s0033291714000610
发表时间: 2014-10-01
影响因子: 6.9
作者:
Harrow, M.;Jobe, T. H.;Faull, R. N.
通讯作者: Faull, R. N.
DOI: 10.1186/s13063-015-0888-6
发表时间: 2015-08-13
期刊: TRIALS
影响因子: 2.5
作者:
Craig, Tom K. J.;Rus-Calafell, Mar;Garety, Philippa
通讯作者: Garety, Philippa
DOI: 10.1016/j.jbi.2016.09.015
发表时间: 2016-12-01
影响因子: 4.5
作者:
Fernandez-Caballero, Antonio;Martinez-Rodrigo, Arturo;Fernandez-Sotos, Alicia
通讯作者: Fernandez-Sotos, Alicia
DOI: 10.1007/s11042-011-0786-1
发表时间: 2012-05-01
影响因子: 3.6
作者:
Pogorelc, Bogdan;Bosnic, Zoran;Gams, Matjaz
通讯作者: Gams, Matjaz
DOI: 10.1080/2326263x.2014.912881
发表时间: 2014-01-01
影响因子: 2.1
作者:
Muehl, Christian;Allison, Brendan;Chanel, Guillaume
通讯作者: Chanel, Guillaume